Dolby Laboratories, Inc.
DLB · NYSE
9/26/2025 | 9/30/2024 | 9/27/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $1,349 | – | $1,274 | $1,300 |
| % Growth | – | – | -2% | – |
| Cost of Goods Sold | $160 | – | $140 | $153 |
| Gross Profit | $1,189 | – | $1,133 | $1,147 |
| % Margin | 88.1% | – | 89% | 88.3% |
| R&D Expenses | $262 | – | $264 | $272 |
| G&A Expenses | $287 | – | $0 | $0 |
| SG&A Expenses | $647 | – | $605 | $613 |
| Sales & Mktg Exp. | $361 | – | $0 | $0 |
| Other Operating Expenses | $15 | – | $0 | $0 |
| Operating Expenses | $924 | – | $869 | $884 |
| Operating Income | $265 | – | $265 | $263 |
| % Margin | 19.6% | – | 20.8% | 20.2% |
| Other Income/Exp. Net | $39 | – | $48 | -$13 |
| Pre-Tax Income | $303 | – | $312 | $250 |
| Tax Expense | $47 | – | $48 | $48 |
| Net Income | $255 | – | $262 | $201 |
| % Margin | 18.9% | – | 20.6% | 15.4% |
| EPS | 2.66 | – | 2.74 | 2 |
| % Growth | – | – | 37% | – |
| EPS Diluted | 2.62 | – | 2.69 | 1.96 |
| Weighted Avg Shares Out | 96 | – | 96 | 96 |
| Weighted Avg Shares Out Dil | 97 | – | 97 | 98 |
| Supplemental Information | – | – | – | – |
| Interest Income | $15 | – | $34 | $28 |
| Interest Expense | $0 | – | $0 | $0 |
| Depreciation & Amortization | $99 | – | $87 | $96 |
| EBITDA | $379 | – | $400 | $346 |
| % Margin | 28.1% | – | 31.4% | 26.6% |